Patents Assigned to Synthrox, Inc.
  • IL-15 conjugates and uses thereof
    Patent number: 12344648
    Abstract: Disclosed herein are interleukin (IL)-15 conjugates and use in the treatment of one or more indications. Also described herein include pharmaceutical compositions and kits comprising one or more of IL-15 conjugates. In some embodiments, at least one amino acid residue in the IL-15 conjugate is replaced by the structure of Formula (I) described herein.
    Type: Grant
    Filed: August 21, 2020
    Date of Patent: July 1, 2025
    Assignee: Synthrox, Inc.
    Inventors: Carolina E. Caffaro, Jerod Ptacin, Marcos Milla